1. Home
  2. RVNC vs RPAY Comparison

RVNC vs RPAY Comparison

Compare RVNC & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • RPAY
  • Stock Information
  • Founded
  • RVNC 1999
  • RPAY 2006
  • Country
  • RVNC United States
  • RPAY United States
  • Employees
  • RVNC N/A
  • RPAY N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • RPAY Business Services
  • Sector
  • RVNC Health Care
  • RPAY Consumer Discretionary
  • Exchange
  • RVNC Nasdaq
  • RPAY Nasdaq
  • Market Cap
  • RVNC 599.6M
  • RPAY 688.3M
  • IPO Year
  • RVNC 2014
  • RPAY N/A
  • Fundamental
  • Price
  • RVNC $3.84
  • RPAY $8.03
  • Analyst Decision
  • RVNC Buy
  • RPAY Strong Buy
  • Analyst Count
  • RVNC 10
  • RPAY 7
  • Target Price
  • RVNC $10.23
  • RPAY $12.29
  • AVG Volume (30 Days)
  • RVNC 2.9M
  • RPAY 674.7K
  • Earning Date
  • RVNC 11-07-2024
  • RPAY 11-12-2024
  • Dividend Yield
  • RVNC N/A
  • RPAY N/A
  • EPS Growth
  • RVNC N/A
  • RPAY N/A
  • EPS
  • RVNC N/A
  • RPAY N/A
  • Revenue
  • RVNC $256,945,000.00
  • RPAY $310,758,000.00
  • Revenue This Year
  • RVNC $20.36
  • RPAY $9.21
  • Revenue Next Year
  • RVNC $31.66
  • RPAY $7.86
  • P/E Ratio
  • RVNC N/A
  • RPAY N/A
  • Revenue Growth
  • RVNC 25.82
  • RPAY 5.95
  • 52 Week Low
  • RVNC $2.30
  • RPAY $7.04
  • 52 Week High
  • RVNC $9.75
  • RPAY $11.27
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 34.28
  • RPAY 47.53
  • Support Level
  • RVNC $3.64
  • RPAY $7.76
  • Resistance Level
  • RVNC $4.37
  • RPAY $8.14
  • Average True Range (ATR)
  • RVNC 0.33
  • RPAY 0.42
  • MACD
  • RVNC -0.11
  • RPAY -0.06
  • Stochastic Oscillator
  • RVNC 18.39
  • RPAY 13.57

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About RPAY Repay Holdings Corporation

Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segment, Consumer Payment and Business Payments.

Share on Social Networks: